Literature for trandolapril (XM02.001 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2016
1. Li,X., Liu,C., Wu,M., Zhang,H., Sun,Y., Cheng,L., Chen,H., Liu,C., Yang,L., Zhang,Q., Cao,Y., Gu,J. and Ding,Y.
   Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of trandolapril, an effective angiotensin-converting enzyme inhibitor, in healthy Chinese subjects
   Eur J Drug Metab Pharmacokinet (2016) 41, 373-384. PubMed  Europe PubMed DOI  I
2005
2. Tan,J., Wang,J.M. and Leenen,F.H.
   Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats
   Am J Hypertens (2005) 18, 158-164. PubMed  Europe PubMed DOI  I
2001
3. Shionoiri,H., Takasaki,I., Minamisawa,K., Ishizuka,H., Konno,K., Naganuma,H., Sasahara,K. and Kawahara,Y.
   Trandolaprilat, an angiotensin-converting enzyme inhibitor, is not excreted in bile via an ATP-dependent active transporter (cMOAT)
   Hypertens Res (2001) 24, 235-240. PubMed  Europe PubMed DOI  I